Common Contracts

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING...

Collaboration and License Agreement • November 6th, 2015 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  November 6th, 2015
• Company
  Fate Therapeutics Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”), effective as of May 4, 2015 (the “Effective Date”), is made by and between Fate Therapeutics, Inc., a Delaware corporation, having a principal place of business at 3535 General Atomics Court, Suite 200, San Diego, CA 92121 (“Fate”), and Juno Therapeutics, Inc., a Delaware corporation, having a place of business at 307 Westlake Ave N, 300, Seattle, WA 98109 (“Juno”).

COLLABORATION AND LICENSE AGREEMENT

Collaboration and License Agreement • August 5th, 2015 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  August 5th, 2015
• Company
  Fate Therapeutics Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”), effective as of May 4, 2015 (the “Effective Date”), is made by and between Fate Therapeutics, Inc., a Delaware corporation, having a principal place of business at 3535 General Atomics Court, Suite 200, San Diego, CA 92121 (“Fate”), and Juno Therapeutics, Inc., a Delaware corporation, having a place of business at 307 Westlake Ave N, 300, Seattle, WA 98109 (“Juno”).